Rosanna Sutherby, Pharm.D.

Articles

University of Miami Researchers Receive $2.9 Million to Study IBD Genetics in Hispanic Population

February 03, 2023

Article

Research by Maria T. Abreu, M.D., and Jacob McCauley, Ph.D., should help fill a gap in the research of the genetics of inflammatory bowel disease, including ulcerative colitis.

For Ulcerative Colitis, Two First-In-Class Candidates and an Interleukin-23 Competition

February 01, 2023

Article

A Swedish and a French company have treatments with novel mechanisms of action in late-stage development. Meanwhile, AbbVie, Janssen and Eli Lilly are vying to get the first interleukin-23 inhibitor for ulcerative colitis on the market.

Study Links Early Progression Independent of Relapse Activity to Worse Long-term Disability in Patients with MS

January 25, 2023

Article

Spanish researchers found that progression of multiple sclerosis that was independent of relapses of the disease was associated with worse long-term outcomes.

Dampened Response to COVID-19 Vaccines in Rituxan-Treated Patients with MS May Improve with Extended Dosing Intervals

January 24, 2023

Article

A study by Kaiser Permanente researchers found that the overall the risk of COVID-19-related hospitalization was low in vaccinated individuals with multiple sclerosis, regardless of whether participants had received Rituxan treatment. Still, the findings suggest that spacing out vaccination may offer added protection against COVID-19.

Microscopic Intestinal Inflammation Linked to Increased Risk of Preterm Birth in Women with Ulcerative Colitis

January 23, 2023

Article

Other adverse outcomes were not linked to histological inflammation, according to results of a Swedish study.

Remote Monitoring of Daily Step Counts Could Help Clinicians Track Changes in Disability in Patients with MS

January 16, 2023

Article

Researchers used a Fitbit Flex2 to examine the correlation between step counts and changes in the brain and spinal cord associated with multiple sclerosis.